Johnson & Johnson reaches $5.5B settlement for talc-related ovarian cancer litigation

Johnson & Johnson has agreed to a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging its baby powder products caused ovarian cancer. The agreement aims to conclude over a decade of litigation, though the finalization of the bankruptcy-linked settlement process remains subject to court approval.